Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands.

Autor: de Jong BC; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Nourdine S; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros., Bergeman AT; Heart Centre, Department of Cardiology, Amsterdam UMC location AMC, University of Amsterdam, Amsterdam, the Netherlands., Salim Z; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros., Grillone SH; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros., Braet SM; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Wirdane Abdou M; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros., Snijders R; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium., Ronse M; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium., Hoof C; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Tsoumanis A; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Ortuño-Gutiérrez N; Damien Foundation, Brussels, Belgium., der Werf CV; Heart Centre, Department of Cardiology, Amsterdam UMC location AMC, University of Amsterdam, Amsterdam, the Netherlands., Piubello A; Damien Foundation, Brussels, Belgium., Mzembaba A; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros., Assoumani Y; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros.; Damien Foundation, Brussels, Belgium., Hasker E; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Publikováno v: PLoS medicine [PLoS Med] 2024 Oct 21; Vol. 21 (10), pp. e1004453. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).

Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial.

Autor: Hasker E; Institute of Tropical Medicine, Antwerp, Belgium. Electronic address: ehasker@itg.be., Assoumani Y; National Tuberculosis and Leprosy Control Program, Moroni, Comoros., Randrianantoandro A; National Leprosy Control Program, Antananarivo, Madagascar., Ramboarina S; Fondation Raoul Follereau, Antananarivo, Madagascar., Braet SM; Institute of Tropical Medicine, Antwerp, Belgium., Cauchoix B; Fondation Raoul Follereau, Antananarivo, Madagascar., Baco A; National Tuberculosis and Leprosy Control Program, Moroni, Comoros., Mzembaba A; National Tuberculosis and Leprosy Control Program, Moroni, Comoros., Salim Z; National Tuberculosis and Leprosy Control Program, Moroni, Comoros., Amidy M; National Tuberculosis and Leprosy Control Program, Moroni, Comoros., Grillone S; National Tuberculosis and Leprosy Control Program, Moroni, Comoros., Attoumani N; National Tuberculosis and Leprosy Control Program, Moroni, Comoros., Grillone SH; National Tuberculosis and Leprosy Control Program, Moroni, Comoros., Ronse M; Institute of Tropical Medicine, Antwerp, Belgium., Peeters Grietens K; Institute of Tropical Medicine, Antwerp, Belgium., Rakoto-Andrianarivelo M; Centre d'Infectiologie Charles Mérieux, Antananarivo, Madagascar., Harinjatovo H; National Leprosy Control Program, Antananarivo, Madagascar., Supply P; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France., Snijders R; Institute of Tropical Medicine, Antwerp, Belgium., Hoof C; Institute of Tropical Medicine, Antwerp, Belgium., Tsoumanis A; Institute of Tropical Medicine, Antwerp, Belgium., Suffys P; Oswaldo Cruz Institute, Fiocruz, Laboratory of Molecular Biology Applied to Mycobacteria, Rio de Janeiro, Brazil., Rasamoelina T; Centre d'Infectiologie Charles Mérieux, Antananarivo, Madagascar., Corstjens P; Leiden University Medical Center, Leiden, Netherlands., Ortuno-Gutierrez N; Damien Foundation, Brussels, Belgium., Geluk A; Leiden University Medical Center, Leiden, Netherlands., Cambau E; Inserm, IAME, Université Paris Cité, UMR 1137, Paris, France; AP-HP, Hôpital Bichat, Service de Mycobacteriologie Specialisee et de Reference, Paris, France., de Jong BC; Institute of Tropical Medicine, Antwerp, Belgium.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Jun; Vol. 12 (6), pp. e1017-e1026.

Use of the Lung Flute ECO to assist in sputum collection for tuberculosis testing: a randomised crossover trial.

Autor: Mbuli C; Center for Health Promotion and Research, Bamenda, Cameroon., Vuchas C; Center for Health Promotion and Research, Bamenda, Cameroon., Konso J; Center for Health Promotion and Research, Bamenda, Cameroon., Adamou Mana Z; Center for Health Promotion and Research, Bamenda, Cameroon., Ngangue YR; Center for Health Promotion and Research, Bamenda, Cameroon., Esther N; Bamenda Regional Hospital, Bamenda, Cameroon., Nyah Ndi N; Cameroon Baptist Convention Health Services and Baptist Institute of Health Sciences, Bamenda, Cameroon., Wandji IAG; National TB Program - Littoral Region, Douala, Cameroon., Fundoh M; National TB Program - Northwest Region, Bamenda, Cameroon., Ganava M; National TB Program - Far North Region, Maroua, Cameroon., Malama T; National TB Program - North Region, Garoua, Cameroon., Denis N; Bamenda Regional Hospital, Bamenda, Cameroon., Teyim P; Tuberculosis Reference Laboratory Douala, Douala, Cameroon., Bisso A; National TB Program, Yaoundé, Cameroon., Snijders R; Institute of Tropical Medicine, Antwerp, Belgium., Mitchell EMH; Institute of Tropical Medicine, Antwerp, Belgium., Hasker E; Institute of Tropical Medicine, Antwerp, Belgium., Soma I; Acoustic Innovations, Tokyo, Japan., Sander M; Center for Health Promotion and Research, Bamenda, Cameroon., Mitarai S; Research Institute of Tuberculosis, Tokyo, Japan.

Publikováno v: ERJ open research [ERJ Open Res] 2024 May 27; Vol. 10 (3). Date of Electronic Publication: 2024 May 27 (Print Publication: 2024).

De vertaling van genetische risicovarianten naar moleculaire ziektemechanismen [The translation of genetic risk variants to molecular disease mechanisms]

Autor: Snijders, G., Snijders, R., Witte, L.D. de

Publikováno v: Tijdschrift voor Psychiatrie, 64, 323-326
Tijdschrift voor Psychiatrie, 64, 5, pp. 323-326

Contains fulltext : 252228.pdf (Publisher’s version ) (Closed access)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1a82cddb6336cf1da23f82a4a91b91dc
https://hdl.handle.net/2066/252228

PRISMA: A novel approach for deriving probabilistic surrogate safety measures for risk evaluation.

Autor: de Gelder E; TNO, Integrated Vehicle Safety, Helmond, The Netherlands; Delft University of Technology, Delft Center for Systems and Control, Delft, The Netherlands. Electronic address: erwin.degelder@tno.nl., Adjenughwure K; TNO, Sustainable Urban Mobility & Safety, The Hague, The Netherlands., Manders J; TNO, Integrated Vehicle Safety, Helmond, The Netherlands., Snijders R; TNO, Monitoring & Control Services, Groningen, The Netherlands., Paardekooper JP; TNO, Integrated Vehicle Safety, Helmond, The Netherlands; Radboud University, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands., Op den Camp O; TNO, Integrated Vehicle Safety, Helmond, The Netherlands., Tejada A; TNO, Integrated Vehicle Safety, Helmond, The Netherlands; Eindhoven University of Technology, Dynamics and Control Group, Eindhoven, The Netherlands., De Schutter B; Delft University of Technology, Delft Center for Systems and Control, Delft, The Netherlands.

Publikováno v: Accident; analysis and prevention [Accid Anal Prev] 2023 Nov; Vol. 192, pp. 107273. Date of Electronic Publication: 2023 Sep 08.